Search Results 531-540 of 1183 for 정보이용료현금ᐲ 【캬툑R2222】【달봉티켓】 boston정보이용료현금さ콘텐츠이용료현금last 구글결제현금화⒬소액결제정책ⓞ소액결제대행사ｌａ핸드폰결제현금화descent

  1. A Study of Danavorexton in People With Obstructive Sleep Apnea After General Anesthesia for Abdominal Surgery - Mayo Clinic

    Overview · Participation eligibility · Participating Mayo Clinic locations · More information · Additional contact information.

  2. Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Patients with Graves' Disease - Mayo Clinic

    Overview · Participation eligibility · Participating Mayo Clinic locations · More information ...

  3. Biomarkers for Intestinal Permeability in Patients With Constipation - Mayo Clinic

    Overview · Participation eligibility · Participating Mayo Clinic locations · More information · Additional contact information.

  4. Utility and Effectiveness of Polygenic Risk Scoring (PRS) for Coronary Artery Disease (CAD) - Mayo Clinic

    About this study · Does PRS/IRS influence how doctors treat or manage patients? · Does PRS/IRS identify patients with increased risk for coronary artery disease?

  5. Sleep Restriction and Parental History of Hypertension - Mayo Clinic

    The purpose of this study is to research the effects of partial sleep deprivation (sleep restriction) in a group of individuals whose parents have high blood ...

  6. DeLisa Fairweather, Ph.D. - Mayo Clinic Faculty Profiles

    SUMMARY. DeLisa Fairweather, Ph.D., is director of translational research for the Department of Cardiovascular Diseases at Mayo Clinic's Florida campus.

  7. Peripheral Nerve Stimulation Therapy for Atrial Fibrillation - Mayo Clinic

    About this study. The purpose of this study is to determine and compare the safety and efficacy of transcutaneous afferent patterned stimulation (TAPS) and ...

  8. Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis - Mayo Clinic

    The purpose of this study is to determine the efficacy of frexalimab in delaying the disability progression and the safety up to approximately 51 months ...

  9. Roll-over Study for Patients Who Have Completed a Prior Novartis-sponsored Sabatolimab (MBG453) Study and Are Judged by the Investigator to Benefit From Continued Treatment With Sabatolimab. - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  10. Open-Label Safety Study of ADS-5102 in PD Patients With LID - Mayo Clinic

    This is a 52-week open-label study to evaluate the safety and tolerability of ADS-5102 oral capsules, an extended release formulation of amantadine, in ...